European Archives - Page 931 of 1171 - European Medical Journal

Continue
8 Mins
31 Oct 2017

Session One: Basal Insulins: Still Innovating After All These Years

Advances in understanding diabetes pathophysiology and treatment permit individualised therapy based on patient-centred treatment plans.
October 2017

EMJ Diabetes 5.1 2017

EMJ would like to welcome you to the latest edition of EMJ Diabetes, a journal dedicated to detailing the vital progression in the treatment of diabetes…
1 Mins
31 Oct 2017

A Role for Connexin Mediated Cell Communication in Fibrosis of Tubular Epithelial Cells in the Diabetic Kidney

Diabetic nephropathy represents the leading cause of end-stage renal disease and is the greatest cause of patient entry into the renal replacement…
2 Mins
31 Oct 2017

Sex Differences in the Diabetes-Associated Risk of Cardiovascular Events in a Young Population

The diabetes-associated excess risk of cardiovascular diseases is known to be higher in women than in men. Find out more in the article
12 Mins
31 Oct 2017

Session Two: Changing the Type 2 Diabetes Mellitus Management Paradigm with Fixed-Ratio Combinations

Fixed-ratio combinations, the co-administration of two injectable therapies in a formulation that can be adjusted through titration, are changing the…
2 Mins
31 Oct 2017

Short-Term Renal Effects of Vildagliptin Addition and Their Clinical and Laboratory Predictors in Insulin-Treated Type 2 Diabetes Mellitus Patients: A Randomised, Comparative, Prospective Clinical Study

Positive renal effects of vildagliptin have been shown by several experimental studies.1,2 Nonetheless, clinical evidence for its renoprotective…
19 Mins
31 Oct 2017

Session Three: Innovating Beyond Glucose Control in Diabetes Care

Advances in treatment offerings are moving beyond classical considerations around glucose control to focus on other aspects of the disease.
2 Mins
31 Oct 2017

Acute Endothelial Benefits of Fat Restriction Over Carbohydrate Restriction in Type 2 Diabetes Mellitus

The current ‘Western cluster’ of non-communicable disorders could be redefined as a dysfunction of the heterogenic, complex, and bidirectional metabolic…
10 Mins
31 Oct 2017

Editor’s Pick: Addressing Hypertension in the Patient with Type 2 Diabetes Mellitus: Pathogenesis, Goals, and Therapeutic Approach

Hypertension is considered a powerful cardiovascular risk factor and is present in up to two-thirds of patients who suffer from diabetes. In the…
10 Mins
31 Oct 2017

Future Treatments of Diabetic Retinopathy: Pharmacotherapeutic Products Under Development

Diabetic macular oedema (DMO) is the leading cause of vision loss in working aged individuals. Macular laser photocoagulation was the primary DMO…
We’ve noticed you’re accessing
from North/South America.